Increasing use of molecular targeting agents and immune checkpoint inhibitors has increased the frequency and broadened the spectrum of lung toxicity, particularly in patients with cancer. In this position paper from the Fleischner Society, the authors provide diagnostic criteria and management recommendations of drug-related pneumonitis for radiologists, clinicians, clinical trialists, and trial sponsors.
- Johkoh, T.
- Lee, K. S.
- Nishino, M.
- Travis, W. D.
- Ryu, J. H.
- Lee, H. Y.
- Ryerson, C. J.
- Franquet, T.
- Bankier, A. A.
- Brown, K. K.
- Goo, J. M.
- Kauczor, H. U.
- Lynch, D. A.
- Nicholson, A. G.
- Richeldi, L.
- Schaefer-Prokop, C. M.
- Verschakelen, J.
- Raoof, S.
- Rubin, G. D.
- Powell, C.
- Inoue, Y.
- Hatabu, H.
